• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library
    Biotech

    UK`s Genus secures FDA approval for PRP gene edit

    REUTERS

    GSK `well positioned` for drug tariffs as vaccine sales slip

    FIERCE PHARMA

    Immunic MS asset misses primary goal of midstage trial

    FIERCE BIOTECH

    US FDA approves J&J`s immune disorder drug

    PRESS RELEASE

    Novartis to buy Regulus in up to $1.7 Billion deal

    REUTERS

    RoosterBio partners Thermo Fisher for Cell Therapy Advancement

    PR NEWSWIRE

    23andMe to have overseer for genetic data in bankruptcy

    REUTERS

    GSK ready for tariffs after exceeding forecasts

    REUTERS

    CHMP recommends label update for Roche`s Phesgo

    GLOBENEWSWIRE

    Immuno-Oncology Results Presented at AACR Annual Meeting 2025

    GLOBENEWSWIRE

    Nanobiotix Shares Ph1 Data on JNJ-1900 in Pancreas

    GLOBENEWSWIRE

    Notice of Annual General Meeting 2025

    GLOBENEWSWIRE

    Er-Kim partners with Puma Biotech to distribute Nerlynx

    GLOBENEWSWIRE

    ADMA Biologics to Report Q1 2025 Financial Results on May 7

    GLOBENEWSWIRE

    Avalo Therapeutics at Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Larimar Therapeutics Reports First Quarter 2025 Financial Results

    GLOBENEWSWIRE

    I-Mab: Givastomig Abstract Accepted for ESMO GI 2025

    GLOBENEWSWIRE

    BriaCell Reports Positive Phase 3 Data at AACR 2025

    GLOBENEWSWIRE

    Gain Therapeutics to Present Poster at IAPRD 2025 Congress

    GLOBENEWSWIRE

    BioAtla to Participate in the Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Valitor to Present Drug Candidate for Wet AMD at Eye Conferences

    GLOBENEWSWIRE

    Altamira Therapeutics Reports Full Year 2024 Financial Results

    GLOBENEWSWIRE

    Cidara Participate at Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Vaxart Completes Ph 1 Trial Enrollment for Norovirus Pill vaccine

    GLOBENEWSWIRE

    Rakovina Therapeutics Announces 2024 Financial Results & Update

    GLOBENEWSWIRE

    PharmAla Issues Q2 Financial Statements

    GLOBENEWSWIRE

    Senti Bio to Present at the Citizens JMP Life Sciences Conference

    GLOBENEWSWIRE

    X-Chem, Orion Pharma collaborate to speed up Drug Discovery

    GLOBENEWSWIRE

    BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Shows Growth

    GLOBENEWSWIRE

    Onconetix Receives Additional Notice from Nasdaq

    GLOBENEWSWIRE

    OBI Pharma`s OBI-902 Phase 1/2 Study IND Cleared by FDA

    GLOBENEWSWIRE

    Sinovac Sets Record and Distribution Dates for Cash Dividend

    BUSINESSWIRE

    Adicet Bio to Join Fireside Chat at Citizens JMP Conference

    BUSINESSWIRE

    Verily Receives Research Grant for Parkinson`s Molecular Dataset

    BUSINESSWIRE

    Sunflower Therapeutics partners with Optimal Biotech Group

    BUSINESSWIRE

    Innate files 2024 Universal Registration Document & Annual Report

    BUSINESSWIRE

    PanGIA Biotech to Present Collaborative Research at ASCO 2025

    BUSINESSWIRE

    Vir Biotechnology to Report Q1 2025 Results on May 7, 2025

    BUSINESSWIRE

    Quince Therapeutics to Present at Life Sciences Conference

    BUSINESSWIRE

    Adicet Bio Reports Inducement Grants under Nasdaq Rule 5635(c)(4)

    BUSINESSWIRE

    Domain Therapeutics Presents Novel Oncology Data at AACR 2025

    PR NEWSWIRE

    INOVIO to Present at Upcoming Scientific and Investor Conferences

    PR NEWSWIRE

    Ingenium Therapeutics gets FDA nod for Gengleucel Ph 2 in MRD+AML

    PR NEWSWIRE

    Athos Therapeutics Co-Founder Dr. Michael E. Jung Wins Chemistry

    ACCESSWIRE

    Risen Pharma presents posters at 2025 AACR Annual Meeting

    ACCESSWIRE

    Merck starts $1 billion Biologics Center in Delaware, US

    PRESS RELEASE

    Lilly pens $13M upfront oligonucleotide AI pact with Creyon Bio

    FIERCE BIOTECH

    Scipher Medicine, InnoSIGN Partner to Advance Precision Medicine

    ACCESSWIRE

    Novartis axes osteoarthritis asset and radioligand therapy

    FIERCE BIOTECH

    Daiichi Sankyo reports solid launch for touted ADC Datroway

    FIERCE PHARMA

    23andMe to have overseer for genetic data in bankruptcy

    REUTERS

    Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

    ACCESSWIRE

    BrainStorm`s NurOwn® Data Chosen for ISCT 2025 Presentation

    PR NEWSWIRE

    WuXi Biologics Releases 2024 Sustainability Report

    PR NEWSWIRE

    Genprex Collab Positive Preclinical Data on Diabetes Gene Therapy

    PR NEWSWIRE

    Novavax Appoints Charles Newton to Board of Directors

    PR NEWSWIRE

    Inovio to Report Q1 2025 Financial Results on May 13

    PR NEWSWIRE

    GiftHealth Appoints Chip Parkinson as CEO to Accelerate Growth

    PR NEWSWIRE

    Metabolon Launches Microbiome Research Solution with New Panel

    PR NEWSWIRE

    Kytopen, Aldevron Advance CRISPR Cell Therapy Workflow

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.